Denka Co Ltd
TSE:4061
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
|
Denka Co Ltd
TSE:4061
|
268.4B JPY |
Loading...
|
|
| JP |
|
JSR Corp
TSE:4185
|
903.4B JPY |
Loading...
|
|
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR |
Loading...
|
|
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD |
Loading...
|
|
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
612T IDR |
Loading...
|
|
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
169.3B CNY |
Loading...
|
|
| US |
|
Dow Inc
NYSE:DOW
|
21.7B USD |
Loading...
|
|
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
132B CNY |
Loading...
|
|
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
590.8B TWD |
Loading...
|
|
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
17.4B USD |
Loading...
|
|
| KR |
|
LG Chem Ltd
KRX:051910
|
23.7T KRW |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
Denka Co Ltd
Glance View
Denka Co., Ltd. is a fascinating player weaving its intricate narrative into the fabric of the industrial world, rooted in innovation and diversification. Founded in 1915, Denka has evolved from a pioneer in the realm of carbide chemistry to a dynamic force in advanced materials. Today's Denka is a multi-faceted conglomerate operating in several key industries, including chemicals, electronics, healthcare, and infrastructure. The company’s strategy revolves around leveraging its chemical expertise to create high-performance materials. These range from functional elastomers and resins to specialty fertilizers and cement additives. The essence of Denka’s business model lies in turning scientific breakthroughs into practical solutions that enhance everyday life, making its products indispensable across a broad spectrum of industries. The company's ability to generate revenue is tightly linked to its commitment to research and development. By continually refining their production processes, Denka ensures their products remain at the cutting edge of performance and sustainability. In the healthcare sector, Denka has made strides with its influenza vaccine, leveraging its pharmaceutical know-how to meet growing global health demands. Meanwhile, its conductive materials are critical in the burgeoning electronics and electric vehicle markets, meeting the demand for more efficient, eco-friendly components. Denka’s financial well-being is further strengthened by its extensive global network, which allows it to tap into diverse markets, offsetting the volatility inherent in any single industry. Through strategic partnerships and a robust value chain, Denka continues to position itself at the confluence of tradition and innovation, shaping a sustainable future for itself and its clientele.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Denka Co Ltd is -3%, which is below its 3-year median of 1.1%.
Over the last 3 years, Denka Co Ltd’s Net Margin has decreased from 5.6% to -3%. During this period, it reached a low of -3.1% on Mar 31, 2025 and a high of 5.6% on Aug 30, 2022.